|

Lorlatinib 100 mg Clinical Trials

1 actively recruiting trial

Also known as: LORVIQUA

Top Sponsors

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Indications

  • Sex Disorder1
  • Erectile Dysfunction1
  • Hypogonadism, Male1
  • NSCLC Stage IV1
  • Lung Cancer1

Other1 trial

ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.